Support women in science at Burnet Institute
Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Hepatitis B, 2022 (17)
November, 2022 (1)
- Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions.
Wallace J, Richmond J, Howell J, Hajarizadeh B, Power J, Treloar C, Revill PA, Cowie B, Wang S, Stoové M, Pedrana A, Hellard M
Viruses. 2022 Nov; 14(11):2542
October, 2022 (2)
- HBV continuum of care using community- and hospital-based screening interventions in Senegal: Results from the PROLIFICA programme.
Sow A, Lemoine M, Toure PS, Diop M, Lo G, De Veiga J, Pape OT, Seck K, Ndow G, Bojang L, Kane A, Oudiane M, Howell J, Nayagam S, Moutchia J, Chemin I, Mendy M, Toure-Kane C, Thursz M, Ka M, Shimakawa Y, Mboup S
JHEP Rep. 2022 Oct; 4(10):100533 - Validation of novel point-of-care test for alanine aminotransferase measurement: A pilot cohort study.
Howell J, Traeger MW, Williams B, Layton C, Doyle JS, Latham N, Draper B, Bramwell F, Membrey D, McPherson M, Roney J, Stoové M, Thompson AJ, Hellard ME, Pedrana A
Clin Liver Dis (Hoboken). 2022 Oct; 20(4):136-139
September, 2022 (1)
- Women with hepatitis B: how mothers with chronic hepatitis B understand and experience the prevention of mother-to-child transmission interventions in Victoria, Australia.
Yussf N, Wallace J, Perrier M, Romero N, Cowie B, Allard N
Aust J Prim Health. 2022 Sep; 28(6):514-521
August, 2022 (1)
- Bridging the gap to achieve viral hepatitis mortality targets.
Flores E, Howell J
Lancet Gastroenterol Hepatol. 2022 Aug; 7(8):691-692
June, 2022 (1)
- A survey of knowledge, attitudes, barriers and support needs in providing hepatitis B care among GPs practising in Australia.
Xiao Y, van Gemert C, Howell J, Wallace J, Richmond J, Adamson E, Thompson A, Hellard M
BMC Prim Care. 2022 Jun; 23(1):137
May, 2022 (3)
- The unvirtuous cycle of discrimination affecting people with hepatitis B: a multi-country qualitative assessment of key-informant perspectives.
Freeland C, Mendola L, Cheng V, Cohen C, Wallace J
Int J Equity Health. 2022 May; 21(1):77 - Evaluating the potential cost-effectiveness of microarray patches to expand access to hepatitis B birth dose vaccination in low-and middle-income countries: A modelling study.
Seaman CP, Mvundura M, Frivold C, Morgan C, Jarrahian C, Howell J, Hellard M, Scott N
PLoS Glob Pub Health. 2022 May; 2(5):e0000394 - The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma.
Flores JE, Thompson AJ, Ryan M, Howell J
Vaccines (Basel). 2022 May; 10(5):793
April, 2022 (1)
- Hepatitis B and pregnancy: understanding the experiences of care among pregnant women and recent mothers in metropolitan Melbourne.
Ahad M, Wallace J, Xiao Y, van Gemert C, Bennett G, Darby J, Desmond P, Hall S, Holmes J, Papaluca T, Glasgow S, Thompson A, Hellard M, Doyle J, Howell J
BMC Public Health. 2022 Apr; 22(1):817
March, 2022 (3)
- Understanding how to live with hepatitis B: a qualitative investigation of peer advice for Chinese people living with hepatitis B in Australia.
Wallace J, Xiao Y, Howell J, Thompson A, Allard N, Adamson E, Richmond J, Hajarizadeh B, Eagle M, Doyle J, Hellard M
BMC Public Health. 2022 Mar; 22(1):536 - Making child's play of tolerance: Defining the immune-viral interplay during combination entecavir and pegylated interferon therapy for immune tolerant hepatitis B infection.
Howell J, Hellard M
Hepatology. 2022 Mar; 76(3):554-557 - Australian consensus recommendations for the management of hepatitis B.
Lubel JS, Strasser SI, Thompson AJ, Cowie BC, MacLachlan J, Allard NL, Holmes J, Kemp WW, Majumdar A, Iser D, Howell J, Matthews GV
Med J Aust. 2022 Mar; 216(9): 478-486
January, 2022 (4)
- The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality.
Karlsen TH, Sheron N, Zelber-Sagi S, Carrieri P, Dusheiko G, Bugianesi E, Pryke R, Hutchinson SJ, Sangro B, Martin NK, Cecchini M, Dirac MA, Belloni A, Serra-Burriel M, Ponsioen CY, Sheena B, Lerouge A, Devaux M, Scott N, Hellard M, Verkade HJ, Sturm E, Marchesini G, Yki-Järvinen H, Byrne CD, Targher G, Tur-Sinai A, Barrett D, Ninburg M, Reic T, Taylor A, Rhodes T, Treloar C, Petersen C, Schramm C, Flisiak R, Simonova MY, Pares A, Johnson P, Cucchetti A, Graupera I, Lionis C, Pose E, Fabrellas N, Ma AT, Mendive JM, Mazzaferro V, Rutter H, Cortez-Pinto H, Kelly D, Burton R, Lazarus JV, Ginès P, Buti M, Newsome PN, Burra P, Manns MP
Lancet. 2022 Jan; 399(10319):61-116 - Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A.
Xu H, Locarnini S, Wong D, Hammond R, Colledge D, Soppe S, Huynh T, Shaw T, Thompson AJ, Revill PA, Hogarth PM, Wines BD, Walsh R, Warner N
J Hepatol. 2022 Jan; 76(1):34-45 - Understanding 'risk' in families living with mixed blood-borne viral infection status: The doing and undoing of 'difference'.
Persson A, Smith AK, Wallace J, Valentine K, Bryant J, Hamilton M, Newman CE
Health. 2022 Jan; 26(3):284-301 - Social impacts of living with chronic hepatitis B in South Sudanese community in Australia.
Mude WW, Fisher CM, Richmond J, Gautier RL, Wallace J
Ethn Health. 2022 Jan; 27(3):529-541
Year
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
- 1998
- 1997
- 1996
- 1995
- 1994
- 1993
- 1992
- 1991
- 1990
- 1989
- 1988
- 1987
- 1982
- 1981
- 1955
Program
- All
- Executive (0)
- Healthy Mothers, Healthy Babies (HMHB) (2)
- Towards Eliminating HIV (20)
- Strategic Funding & Partnerships Executive Team (0)
- Disease Elimination (264)
- Maternal, Child and Adolescent Health (200)
- Philanthropy and Supporter Engagement (0)
- Health Security and Pandemic Preparedness (104)
- Eliminate Malaria (42)
- Eliminate Tuberculosis (TB) (14)
- Finance (0)
- Healthy Ageing (1)
- Human Resources (0)
- Burnet Honorary Research Fellows (8)
- Research Support and Facilities (0)
- Harm Reduction (8)
- Information Technology (0)
- Burnet Vaccine Initiative (0)
- Laboratory Services (0)
- Eliminate Viral Hepatitis (37)
- Education & Training (0)
- Infectious Diseases Elimination (2)
- Support Services Group (0)
- Project Management and Quality Assurance Office (0)
- Marketing and Communications (0)
- International Operations (1)
- Commercialisation, Innovation and Industry Partnerships (0)
Discipline
- All
- Life Sciences (0)
- Public Health (0)
- International Development (0)
Research Theme
- All
- HIV and AIDS (27)
- Sexually Transmitted Infections (STIs) (8)
- Maternal and Child Health (60)
- Malaria (47)
- Immune Disease and Cancer (4)
- Hepatitis B (17)
- Hepatitis C (30)
- Global infectious disease threats (7)
- Injecting Drug Use (36)
- Alcohol and Other Drugs (38)
- Tuberculosis (TB) (14)
- Young People's Health (9)
- Justice Health (11)
- Nutrition (3)
- Sexual and Reproductive Health (12)
- Infectious Disease Modelling (15)
- Infectious Diseases Surveillance (2)
- LGBTQIA+ (6)
- Influenza (1)
- Global Adolescent Health (9)
- COVID-19 (novel coronavirus) (50)
